Interest of the obinutuzumab (GA101) in combination with chemotherapy in refractory indolent non-Hodgkin's lymphoma to rituximab: results of the Phase III Gadolin

被引：0

作者：

Philippe, Laure

机构：

来源：

HEMATOLOGIE | 2016年 / 22卷 / 05期

关键词：

D O I：

10.1684/hma.2016.1181

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：311 / +

页数：4

共 9 条

[1]

Bartlett NL, 2014, BLOOD, V124, P800

[2] Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study [J].

Czuczman, Myron S. ;

Fayad, Luis ;

Delwail, Vincent ;

Cartron, Guillaume ;

Jacobsen, Eric ;

Kuliczkowski, Kazimierz ;

Link, Brian K. ;

Pinter-Brown, Lauren ;

Radford, John ;

Hellmann, Andrzej ;

Gallop-Evans, Eve ;

DiRienzo, Christine G. ;

Goldstein, Nancy ;

Gupta, Ira ;

Jewell, Roxanne C. ;

Lin, Thomas S. ;

Lisby, Steen ;

Schultz, Martin ;

Russell, Charlotte A. ;

Hagenbeek, Anton .

BLOOD, 2012, 119 (16) :3698-3704

[3] A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma [J].

Gerecitano, John F. ;

Roberts, Andrew W. ;

Seymour, John F. ;

Wierda, William G. ;

Kahl, Brad S. ;

Pagel, John M. ;

Puvvada, Soham ;

Kipps, Thomas J. ;

Anderson, Mary Ann ;

Dunbar, Martin ;

Zhu, Ming ;

Gressick, Lori ;

Wagner, Lindsay ;

Kim, Su Young ;

Enschende, Sari Heitner ;

Humerickhouse, Rod A. ;

Davids, Matthew S. .

BLOOD, 2015, 126 (23)

[4] PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma [J].

Gopal, Ajay K. ;

Kahl, Brad S. ;

de Vos, Sven ;

Wagner-Johnston, Nina D. ;

Schuster, Stephen J. ;

Jurczak, Wojciech J. ;

Flinn, Ian W. ;

Flowers, Christopher R. ;

Martin, Peter ;

Viardot, Andreas ;

Blum, Kristie A. ;

Goy, Andre H. ;

Davies, Andrew J. ;

Zinzani, Pier Luigi ;

Dreyling, Martin ;

Johnson, Dave ;

Miller, Langdon L. ;

Holes, Leanne ;

Li, Daniel ;

Dansey, Roger D. ;

Godfrey, Wayne R. ;

Salles, Gilles A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) :1008-1018

[5] Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma Results From a Multicenter Study [J].

Kahl, Brad S. ;

Bartlett, Nancy L. ;

Leonard, John P. ;

Chen, Ling ;

Ganjoo, Kristen ;

Williams, Michael E. ;

Czuczman, Myron S. ;

Robinson, K. Sue ;

Joyce, Robin ;

van der Jagt, Richard H. ;

Cheson, Bruce D. .

CANCER, 2010, 116 (01) :106-114

[6] Analysis of Minimal Residual Disease in Follicular Lymphoma Patients in Gadolin, a Phase III Study of Obinutuzumab Plus Bendamustine Versus Bendamustine in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma [J].

Pott, Christiane ;

Belada, David ;

Danesi, Nathalie ;

Fingerle-Rowson, Guenter ;

Gribben, John ;

Harbron, Chris ;

Hoster, Eva ;

Kahl, Brad S. ;

Mundt, Kirsten ;

Sebban, Catherine ;

Sehn, Laurie H. ;

Cheson, Bruce D. .

BLOOD, 2015, 126 (23)

[7] Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial [J].

Rummel, Mathias J. ;

Niederle, Norbert ;

Maschmeyer, Georg ;

Banat, G. Andre ;

von Gruenhagen, Ulrich ;

Losem, Christoph ;

Kofahl-Krause, Dorothea ;

Heil, Gerhard ;

Welslau, Manfred ;

Balser, Christina ;

Kaiser, Ulrich ;

Weidmann, Eckhart ;

Duerk, Heinz ;

Ballo, Harald ;

Stauch, Martina ;

Roller, Fritz ;

Barth, Juergen ;

Hoelzer, Dieter ;

Hinke, Axel ;

Brugger, Wolfram .

LANCET, 2013, 381 (9873) :1203-1210

[8] Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study [J].

Salles, Gilles A. ;

Morschhauser, Franck ;

Solal-Celigny, Philippe ;

Thieblemont, Catherine ;

Lamy, Thierry ;

Tilly, Herve ;

Gyan, Emmanuel ;

Lei, Guiyuan ;

Wenger, Michael ;

Wassner-Fritsch, Elisabeth ;

Cartron, Guillaume .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) :2920-+

[9] Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial [J].

Sehn, Laurie H. ;

Chua, Neil ;

Mayer, Jiri ;

Dueck, Gregg ;

Trneny, Marek ;

Bouabdallah, Kamal ;

Fowler, Nathan ;

Delwail, Vincent ;

Press, Oliver ;

Salles, Gilles ;

Gribben, John ;

Lennard, Anne ;

Lugtenburg, Pieternella J. ;

Dimier, Natalie ;

Wassner-Fritsch, Elisabeth ;

Fingerle-Rowson, Guenter ;

Cheson, Bruce D. .

LANCET ONCOLOGY, 2016, 17 (08) :1081-1093

← 1 →